Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00175955
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : December 6, 2013
Information provided by:
UCB Pharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2005
  Study Completion Date : December 2005